JPRN-UMIN000020903
Recruiting
Phase 2
A Phase 2 Trial of Multimodal Treatment based on VDC-IE with Interval Compressed Schedule by using G-CSF for Patients with Non-metastatic Ewing Sarcoma Family Tumor - Interval Compressed VDC-IE for Non-metastatic ESFT (JESS14)
Japan Ewing Sarcoma Study Group0 sites66 target enrollmentFebruary 5, 2016
Conditionson-metastatic Ewing Sarcoma Family Tumor
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- on-metastatic Ewing Sarcoma Family Tumor
- Sponsor
- Japan Ewing Sarcoma Study Group
- Enrollment
- 66
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients with synchronous or metachronous concomitant malignancies. 2\)Patients who are pregnant or breast feeding mother. 3\)Patients with mental disorder who is considered inappropriate for study participation. 4\)Patients with heart disease which required any therapy. 5\)Patients with active infection which required any therapy. 6\)Patients with any other inappropriate condition for study participation judged by physician. 7\)HBs antigen positive. HBs antigen negative but HBc antibody or HBs antibody positive.( exclude HBs antibody positive due to HBV vaccination) 8\)Patients who had continuous steroid therapy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
JESS14Ewing sarcoma family tumorEwing sarcomaC04.557.450.565.575.650.800JPRN-jRCTs021180022Sano Hideki66
Completed
Phase 2
A phase II study of multimodality therapy with introduction chemoradiotherapy before surgery in patients with pathological mediastinal lymph node metastasis (N2 Stage IIIA) non -small cell lung canceron-small cell lung cancerJPRN-UMIN000029435Department of respiratory medicine, Kurashiki Central Hospital20
Recruiting
Not Applicable
Pilot study of multimodality treatment based on a new risk stratification in patients with medulloblastomaJPRN-UMIN000014488Japanese Pediatric Brain Tumor Consortium30
Active, not recruiting
Not Applicable
A Phase 2 Study of combined modality treatment with primary chemotherapy followed by endoscopic laser resection in intermediate stage laryngeal squamous cell carcinoma.SQUAMOUS CELL CARCINOMA OF THE LARYNGXMedDRA version: 6.1Level: PTClassification code 10018395EUCTR2005-001132-72-ITISTITUTO EUROPEO DI ONCOLOGIA42
Active, not recruiting
Phase 2
WJOG11118JPRN-jRCTs041200046Hirotsugu Kenmotsu30